All Topics

Use the tool below to view all available Prova Series

A Pediatrician’s Perspective on Treating Transgender Adolescents
A Pediatrician’s Perspective on Treating Transgender Adolescents
Clinician's Roundtable
A Pediatrician’s Perspective on Treating Transgender Adolescents
- Ramiz Kseri, MD
Discovering Disparities in Diversity: Representation in Clinical Trials
Discovering Disparities in Diversity: Representation in Clinical Trials
Clinician's Roundtable
Discovering Disparities in Diversity: Representation in Clinical Trials
- Jennifer Caudle, DO
- Narjust Duma, MD
Coping with Career Burnout: A Physician's Journey Through Renaissance Art
Coping with Career Burnout: A Physician's Journey Through Renaissance Art
Book Club
Coping with Career Burnout: A Physician's Journey Through Renaissance Art
- Jennifer Caudle, DO
FDA Warns of Serious Immune Reaction with Seizure/BPD Medicine Lamotrigine (Lamictal)
FDA Warns of Serious Immune Reaction with Seizure/BPD Medicine Lamotrigine (Lamictal)
FDA Drug Information Updates
FDA Warns of Serious Immune Reaction with Seizure/BPD Medicine Lamotrigine (Lamictal)
FDA-Approved Gene Therapy Reverses Blindness in Children & Adults
FDA-Approved Gene Therapy Reverses Blindness in Children & Adults
Medical Breakthroughs from Penn Medicine
FDA-Approved Gene Therapy Reverses Blindness in Children & Adults
- Jennifer Caudle, DO
- Jean Bennett, MD, PhD
- Albert Maguire, MD
The Crohn’s & Colitis Foundation's Camp Oasis: A Patient's Perspective
The Crohn’s & Colitis Foundation's Camp Oasis: A Patient's Perspective
Crohn’s & Colitis Foundation Perspectives
The Crohn’s & Colitis Foundation's Camp Oasis: A Patient's Perspective
- Philip Stein, MD
FDA’s Role in Foreign Drug Manufacturing
FDA’s Role in Foreign Drug Manufacturing
FDA Drug Information Updates
FDA’s Role in Foreign Drug Manufacturing
FDA Review: Adding LABAs to ICS Treatment Does Not Significantly Increase Serious Asthma Outcomes Risk
FDA Review: Adding LABAs to ICS Treatment Does Not Significantly Increase Serious Asthma Outcomes Risk
FDA Drug Information Updates
FDA Review: Adding LABAs to ICS Treatment Does Not Significantly Increase Serious Asthma Outcomes Risk
RISK Cohort Study in Crohn's Disease
RISK Cohort Study in Crohn's Disease
Crohn’s & Colitis Foundation Perspectives
RISK Cohort Study in Crohn's Disease
The FDA's Adverse Event Reporting System (FAERS) Public Dashboard
The FDA's Adverse Event Reporting System (FAERS) Public Dashboard
FDA Drug Information Updates
The FDA's Adverse Event Reporting System (FAERS) Public Dashboard
CAR-T Cell Therapy: A Breakthrough Treatment for Fighting Cancer
CAR-T Cell Therapy: A Breakthrough Treatment for Fighting Cancer
Medical Breakthroughs from Penn Medicine
CAR-T Cell Therapy: A Breakthrough Treatment for Fighting Cancer
- Shira Johnson, MD
- Robert Vonderheide, MD
Study Examines Effectiveness of Steroid Medication for Sore Throat
Study Examines Effectiveness of Steroid Medication for Sore Throat
The JAMA Report™
Study Examines Effectiveness of Steroid Medication for Sore Throat
Beyond the Data: Emerging Tickborne Diseases
Beyond the Data: Emerging Tickborne Diseases
Grand Rounds Nation®
Beyond the Data: Emerging Tickborne Diseases
How Do Mortality Rates Vary Based on Where You Live?
How Do Mortality Rates Vary Based on Where You Live?
The JAMA Report™
How Do Mortality Rates Vary Based on Where You Live?
Use of Statins for the Prevention of Cardiovascular Disease
Use of Statins for the Prevention of Cardiovascular Disease
The JAMA Report™
Use of Statins for the Prevention of Cardiovascular Disease
Changes in Clinical Diagnostics and Tracking Infectious Diseases
Changes in Clinical Diagnostics and Tracking Infectious Diseases
Grand Rounds Nation®
Changes in Clinical Diagnostics and Tracking Infectious Diseases

All Topics

Popular

Title

Share on ReachMD